- Previous Close
849.90 - Open
808.00 - Bid 783.20 x --
- Ask 879.60 x --
- Day's Range
849.90 - 849.90 - 52 Week Range
700.00 - 1,400.00 - Volume
14 - Avg. Volume
34 - Market Cap (intraday)
35.451M - Beta (5Y Monthly) 0.14
- PE Ratio (TTM)
-- - EPS (TTM)
-14,276.62 - Earnings Date Nov 18, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Strategic Partners A/S does not have significant operations. Previously, it was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024. The company was incorporated in 2009 and is based in Herlev, Denmark.
www.strategic-partners.dkRecent News: STRAP.CO
View MorePerformance Overview: STRAP.CO
Trailing total returns as of 1/30/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: STRAP.CO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: STRAP.CO
View MoreValuation Measures
Market Cap
35.45M
Enterprise Value
35.45M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.99
Price/Book (mrq)
0.54
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
4.27%
Return on Equity (ttm)
-50.77%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-11.42M
Diluted EPS (ttm)
-14,276.62
Balance Sheet and Cash Flow
Total Cash (mrq)
17.75M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
1.49M